{"product_id":"a-cure-within-scientists-unleashing-the-immune-system-to-kill-cancer-9781621822172","title":"A Cure Within: Scientists Unleashing the Immune System to Kill Cancer","description":"\u003cstrong\u003eIncludes interviews with 2018 Nobel Prize Winners James Allison and Tasuku Honjo\u003c\/strong\u003e \u003cp\u003e\u003c\/p\u003eThe way we treat cancer is about to change forever. This revolution--and it is precisely that--was sparked not by the invention of a new drug, but by the evolution of an entirely new way of thinking about and managing cancer. Going forward, doctors will not use pharmaceuticals to attack tumors--not directly. Rather, the oncologist will treat the patient's immune system with a drug, and then the patient will treat the tumor. \u003cp\u003e\u003c\/p\u003eBased entirely on interviews with the investigators, this book is the story of the immuno-oncology pioneers. It's a story of failure, resurrection, and success. It's a story about science, it's a story about discovery, and intuition, and cunning. It's a peek into the lives and thoughts of some of the most gifted medical scientists on the planet. \u003cp\u003e\u003c\/p\u003eThis is not a textbook. This is a life book. This technology will save\/is saving lives, and the book celebrates the living, breathing, thinking, charming, arrogant, funny, obstinate, amazing human beings who are making immuno-oncology happen. \u003cp\u003e\u003c\/p\u003e\"The stories and lives shared in this book show readers the decades of devotion and passion it takes to imagine a better world and then make it happen. If this book motivates even one more similarly talented and visionary investigator to deliver on their promise it would be a wonderful success.\" -- Clifford A. Hudis, MD, FACP, FASCO\u003cbr\u003eChief Executive Officer, American Society of Clinical Oncology\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eAbout the Author\u003c\/b\u003e\u003cbr\u003e\u003cstrong\u003eNeil Canavan\u003c\/strong\u003e is a veteran journalist specializing in science and medicine, a career he embarked upon after earning a master's degree in molecular and cellular biodynamics from Rutgers University. With more than 15 years of reporting experience, and some 200 feature articles to his credit Neil has written for such news outlets as \u003cem\u003eWebMD\u003c\/em\u003e, \u003cem\u003eMedscape\u003c\/em\u003e, \u003cem\u003eDrug Discovery and Development Magazine\u003c\/em\u003e, and \u003cem\u003eThe Scientist\u003c\/em\u003e. Currently, Neil is a contributing editor to \u003cem\u003eThe Oncology Business Review\u003c\/em\u003e where he has written many articles on the technology of, and clinical outcomes for cancer immunotherapy. \u003cp\u003e\u003c\/p\u003eSince 2014 Neil has held the position of Scientific Advisor at The Trout Group, a New York-based investor relations firm focused on healthcare biotechnology. The Trout Group has 30 clients in the oncology space, with many of those companies pursuing the development of cancer immunotherapies.\u003cbr\u003e","brand":"Cold Spring Harbor Laboratory Press","offers":[{"title":"Default Title","offer_id":50544930423058,"sku":"9781621822172","price":20.99,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0831\/4771\/8930\/files\/img_acbaaa4b-20d8-4c35-baf3-170855ea67d5.jpg?v=1731538645","url":"https:\/\/surprise-castle.myshopify.com\/products\/a-cure-within-scientists-unleashing-the-immune-system-to-kill-cancer-9781621822172","provider":"Surprise Castle","version":"1.0","type":"link"}